Estrogen and tamoxifen interplay with T-3 in male rats: Pharmacologically distinct classes of estrogen responses affecting growth, bone, and lipid metabolism, and their relation to serum GH and IGF-I
Jm. Fitts et al., Estrogen and tamoxifen interplay with T-3 in male rats: Pharmacologically distinct classes of estrogen responses affecting growth, bone, and lipid metabolism, and their relation to serum GH and IGF-I, ENDOCRINOL, 142(10), 2001, pp. 4223-4235
Estrogen (E) and T-3 regulate gene expression by receptor mechanisms that m
ay enable hormonal interplay affecting growth and metabolism. Prior studies
of E and tamoxifen (TM) interplay with T-3 in female rats identified a sub
set of E responses that required T-3 for expression and exhibited large ago
nist responses to TM. In contrast, TM acted more like an antagonist in most
T-3-independent E responses. This study used male rats to further explore
the role of T-3 in E effects on growth and metabolism, and the relation of
such effects to changes in serum GH and IGF-I. Orchidectomized, hypothyroid
rats were treated 6 wk with vehicle, E2 benzoate (E2B), or TM with or with
out T-3. The following parameters were measured: body weight change; tibia
length and bone mineral density; heart and kidney weight; food intake and b
ody temperature; serum levels of glucose, cholesterol, triglycerides, GH, a
nd IGF-I; seminal vesicle weight; and anterior pituitary levels of GH, PRL,
glandular kallikrein, and total protein. Interplay with T-3 contributed to
multiple E effects on growth and metabolism, and some E responses involved
both T-3-dependent and T-3-independent components. Both E2B and TM increas
ed serum GH, but the increases were poorly coupled to IGF-I. Correlation/re
gression analysis of individual rat data sets suggested distinct roles for
GH and IGF-I in specific E effects. E2B and TM effects on somatic growth ex
hibited positive correlations with IGF-I and negative correlations with GH;
effects on bone mineral density and triglycerides exhibited positive corre
lations with GH and negative correlations with IGF-I. Three pharmacological
ly distinct classes of in vivo E responses were identified in this study, a
nd TM displayed a profile of biological activity that may be useful for men
undergoing androgen-deprivation therapy.